Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2021

Apr 24, 2021

61176_rns_2021-04-24_f26c5225-0b4e-4d93-8896-469b9efc3ec2.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

April 24, 2021

ToThe ManagerBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001 ToThe Manager,National Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code- 532523 Scrip Symbol- Biocon

Subject: Confirmation on Large Corporate as per SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

Dear Sir/Madam,

Pursuant to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, we hereby confirm that Biocon Limited does not fall in the category of “Large Corporate” as specified under clause 2.2 of the aforesaid Circular.

Kindly take on record the above information and acknowledge.

Thanking You,

==> picture [240 x 140] intentionally omitted <==

----- Start of picture text ----- Yours faithfully,For Biocon LimitedDigitally signedMAYANK by MAYANKVERMAVERMA Date: 2021.04.2420:46:56 +05'30'_______________Mayank VermaCompany Secretary and Compliance Officer----- End of picture text -----